BlackRock Institutional Trust Company lowers AmSurg stake by 0.2% — 5 quick facts

During the third quarter of fiscal year 2016, BlackRock Institutional Trust Company reduced its stake in Nashville, Tenn.-based AmSurg by 0.2 percent, according to Daily Quint.

Advertisement

Here are five quick facts:

1. BlackRock sold 2,512 AmSurg shares during the quarter.

2. At the quarter’s end, the firm’s stake in AmSurg totaled nearly $106.33 million.

3. AmSurg reported earnings per share of $1.13 during Q3.

4. The ASC company generated revenue reaching $822.2 million for the quarter.

5. On Sept. 26, 2016, Citigroup rated AmSurg shares a “buy.”

More articles on ambulatory surgery centers:
Physicians Endoscopy joint ventures on 43rd ASC; Surgery Partners’ market cap hits $282.6M & more — 5 ASC company notes
Ann & Robert H. Lurie Children’s Hospital of Chicago obtains CON approval for surgery center: 5 highlights
Mednax makes way into radiology space through Radiology Alliance acquisition: 5 things to know

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.